70
Participants
Start Date
Not specified
Study Completion Date
April 30, 1998
Amphotericin B
Beth Israel Med. Ctr. (Mt. Sinai), New York
SUNY - Buffalo, Erie County Medical Ctr., Buffalo
Univ. of Rochester ACTG CRS, Rochester
Hosp. of the Univ. of Pennsylvania CRS, Philadelphia
Howard University Hosp., Div. of Infectious Diseases, ACTU, Washington D.C.
Johns Hopkins Adult AIDS CRS, Baltimore
Alabama Therapeutics CRS, Birmingham
The Ohio State Univ. AIDS CRS, Columbus
Univ. of Cincinnati CRS, Cincinnati
Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis
Indiana Univ. School of Medicine, Wishard Memorial, Indianapolis
Methodist Hosp. of Indiana, Indianapolis
Northwestern University CRS, Chicago
Cook County Hosp. CORE Ctr., Chicago
Weiss Memorial Hosp., Chicago
St. Louis ConnectCare, Infectious Diseases Clinic, St Louis
Univ. of Nebraska Med. Ctr., Durham Outpatient Ctr., Omaha
Queens Med. Ctr., Honolulu
Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu
University of Washington AIDS CRS, Seattle
USC CRS, Los Angeles
Santa Clara Valley Med. Ctr., San Jose
San Mateo County AIDS Program, San Mateo
Univ. of Miami AIDS CRS, Miami
The Ponce de Leon Ctr. CRS, Atlanta
Rush Univ. Med. Ctr. ACTG CRS, Chicago
Washington U CRS, St Louis
NY Univ. HIV/AIDS CRS, New York
Mbeya Med. Research Program, Mbeya Referral Hosp. CRS, Mbeya
Massachusetts General Hospital ACTG CRS, Boston
Bmc Actg Crs, Boston
Puerto Rico-AIDS CRS, San Juan
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH